feed,title,long_url,short_url
Benzinga,Calliditas Starts Dosing In Nefecon Open Label Extension Study In Kidney Disease,https://www.benzinga.com/general/biotech/21/02/19483838/calliditas-starts-dosing-in-nefecon-open-label-extension-study-in-kidney-disease,https://j.mp/3cCUqAE
Benzinga,12 Industrials Stocks Moving In Thursday's Pre-Market Session,https://www.benzinga.com/pre-market-outlook/21/02/19487031/12-industrials-stocks-moving-in-thursdays-pre-market-session,https://j.mp/2NVaCCT
Benzinga,12 Health Care Stocks Moving In Thursday's Pre-Market Session,https://www.benzinga.com/pre-market-outlook/21/02/19487032/12-health-care-stocks-moving-in-thursdays-pre-market-session,https://j.mp/3oPnqaC
Benzinga,12 Consumer Discretionary Stocks Moving In Thursday's Pre-Market Session,https://www.benzinga.com/pre-market-outlook/21/02/19487034/12-consumer-discretionary-stocks-moving-in-thursdays-pre-market-session,https://j.mp/3rpZDjd
